Gland Pharma logo

Gland Pharma financials and balance sheet

NSE: GLANDBSE: 543245Pharmaceuticals & BiotechnologySmall Cap

Last close ₹2,826.80down ₹23.60 (0.83%)BSE ₹2,825.35

Share price at the NSE close on 23 Oct 2026. Previous close ₹2,850.40.

52-week range of traded prices to 23 Oct 2026
₹1,573.60Low, 16 Mar 2026₹3,171.00High, 7 Oct 2026
Market cap
₹46,645 Cr261st largest listed
P/E
41.3
P/B
4.5
Dividend yield
0.71%
ROE
11.6%
ROCE
12.4%
Debt to equity
0.02
Volume, NSE
4,23,05755.6% delivered

6 years at a glance

Consolidated: the company and its subsidiaries together. ₹ crore, years to March.Gland Pharma annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
Peak revenue ₹6,431 Cr, year to Mar 2026

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue6,431
  2. Materials and goods−2,243
  3. Employee costs−1,629
  4. Other expenses−929
  5. Operating profit1,630
  6. Depreciation−424
  7. Other income+316
  8. One-off items−24
  9. Finance costs−33
  10. Profit before tax1,465
  11. Tax−437
  12. Net profit1,027

What the company owns

  • Plant, investments and other assets₹5,516 Cr
  • Cash and bank₹3,359 Cr
  • Receivables₹1,891 Cr
  • Inventory₹1,744 Cr

What pays for it: net worth and liabilities

  • Net worth₹10,358 Cr
  • Other liabilities₹1,076 Cr
  • Owed to suppliers₹834 Cr
  • Borrowings₹243 Cr

Profit and loss

Consolidated, ₹ crore, years to March.Gland Pharma quarterly results

₹ croreMar 2021Filed 18 MayMar 2022Filed 20 MayMar 2023Filed 19 MayMar 2024Filed 23 MayMar 2025Filed 12 JunMar 2026Filed 15 May
Revenue from operations3,4634,4013,6255,6655,6176,431
2,1612,8912,6004,3324,3484,801
Materials and goods bought1,4922,1091,6852,1732,0902,243
Employee costs3113394031,2571,4021,629
Other expenses357443511902856929
Operating profit before depreciation1,3021,5101,0251,3331,2691,630
Operating margin37.6%34.3%28.3%23.5%22.6%25.3%
Materials, % of revenue43.1%47.9%46.5%38.4%37.2%34.9%
Employee costs, % of revenue9.0%7.7%11.1%22.2%25.0%25.3%
Other expenses, % of revenue10.3%10.1%14.1%15.9%15.2%14.5%
Depreciation and amortisation99110147345378424
Operating profit after depreciation1,2031,4008789898911,206
Other income135224240170214316
Finance costs357264233
Profit before one-off items and tax1,3351,6191,1111,1331,0631,489
One-off items00−5600−24
Profit before tax1,3351,6191,0551,1331,0631,465
338407274360364437
Net profit9971,2127817726991,027
Other comprehensive income−10−1−855431
Total comprehensive income9961,2117807657541,458
Net margin28.8%27.5%21.5%13.6%12.4%16.0%

Balance sheet

Consolidated, ₹ crore, at 31 March.

₹ croreMar 2021Filed 18 MayMar 2022Filed 20 MayMar 2023Filed 19 MayMar 2024Filed 23 MayMar 2025Filed 12 JunMar 2026Filed 15 May
5,9037,1587,9598,7249,15110,358
Share capital161616161616
Reserves5,8877,1417,9428,7079,13410,341
444320269243
5135827291,3981,5651,608
809490539509544
Total assets6,4967,8348,77810,66111,22512,511
1,3721,9821,8775,0164,4424,984
5,1245,8526,9015,6456,7837,527
Net debt−3,002−3,244−3,767−1,520−2,287−3,116
Borrowings are counted again inside the liabilities due within a year and after a year.

Cash flow

Consolidated, ₹ crore, years to March.

₹ croreMar 2021Filed 18 MayMar 2022Filed 20 MayMar 2023Filed 19 MayMar 2024Filed 23 MayMar 2025Filed 12 JunMar 2026Filed 15 May
6057913649979151,031
9161,1976751,3031,2691,487
−436−393−418−53−6−254
Receivables−60−527144−32542−279
Inventories−51990−760666−2019
Payables14366121−37927−55
Other working capital1−2177−15−5560
Tax paid−311−407−311−306−354−455
Capital spending229511221390385491
Free cash flow376279143607530541
−1,524−1,0031,208−1,7571,705138
1,2383515−799−433−417
Dividends paid0000329297
Shares bought back000000
Shares issued1,22500000
Net change in cash319−1771,587−1,5602,186752
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only.

Per share

Consolidated, ₹ per share, years to March.Gland Pharma dividend history

₹ per shareMar 2021Filed 18 MayMar 2022Filed 20 MayMar 2023Filed 19 MayMar 2024Filed 23 MayMar 2025Filed 12 JunMar 2026Filed 15 May
Earnings per share₹63.07₹73.81₹47.44₹46.90₹42.40₹62.35
Diluted earnings per share₹62.99₹73.64₹47.43₹46.89₹42.40₹62.28
Dividend per share–––₹20.00₹18.00₹20.00
Book value per share₹360.86₹435.64₹483.23₹529.65₹555.40₹628.67
Dividend payout–––42.6%42.5%32.1%
Shareholder yield−3.0%0.0%0.0%0.0%1.3%1.1%
Market cap at the year end (₹ crore)40,46653,77120,88730,39226,23527,944

Ratios

Consolidated, years to March.Gland Pharma PE ratio and valuation

RatioMar 2021Filed 18 MayMar 2022Filed 20 MayMar 2023Filed 19 MayMar 2024Filed 23 MayMar 2025Filed 12 JunMar 2026Filed 15 May
Revenue growth–27.1%−17.6%56.3%−0.9%14.5%
Operating profit growth–16.0%−32.1%30.1%−4.8%28.4%
Net profit growth–21.5%−35.5%−1.1%−9.6%47.1%
Earnings per share growth–17.0%−35.7%−1.1%−9.6%47.1%
16.9%18.6%10.3%9.3%7.8%10.5%
–1.7 pts−8.2 pts−1.1 pts−1.4 pts2.7 pts
From the net margin–−0.7 pts−4.0 pts−3.8 pts−0.8 pts2.2 pts
From asset turnover–2.5 pts−4.2 pts2.2 pts−1.0 pts0.6 pts
From borrowing–−0.1 pts0.0 pts0.5 pts0.4 pts−0.1 pts
Return on capital employed20.4%19.5%11.0%10.9%9.5%11.4%
Cash conversion60.7%65.3%46.6%129.0%131.0%100.4%
Interest cover352.8267.0117.937.721.236.2
Debt to equity0.000.000.000.040.030.02
Receivable days71998810099107
Inventory days312205421278294284
Payable days9880127145143136
Cash conversion cycle, days285225382234250255
Working capital days169168242169185155
Asset turnover0.530.610.440.580.510.54
Assets per rupee of net worth1.101.101.101.171.221.22
Sales per rupee of plant3.632.942.331.601.501.59
Capital spending to depreciation2.324.641.511.131.021.16
Plant being built, % of plant in use35.4%12.1%11.4%6.7%4.0%8.4%

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
8.7%
Cash from operations against operating profit
63.3%
Measure5 years3 years
Revenue growth, yearly rate13.2%21.1%
Profit growth, yearly rate0.6%9.6%
Return on equity, average11.3%9.2%
Return on capital employed, average12.5%10.6%
Operating margin, average26.8%23.8%
Net margin, average18.2%14.0%
Asset turnover, average0.540.55
Cash conversion cycle, days, average269246
Interest cover, average96.031.7
Debt to equity, average0.020.03

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations4,0982,9431,031
Cash from investing29186138
Cash from financing−1,600−1,650−417
Capital spending1,9971,265491
Dividends paid626626297
Shares bought back000
Shares issued for cash000
Borrowings raised494923
Borrowings repaid93493494

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––4569
Altman Z-scorePublished threshold 1.8144.3751.0518.2311.9210.1110.42
Beneish M-scorePublished threshold −1.78–−1.51−2.84−1.27−2.85−2.18
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets–19.87−9.5315.77−17.55−1.19
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––0.590.781.011.18
Receivables growth less revenue growthOur threshold 0 percentage points–51.58−9.6722.59−1.8510.22
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–−48.4084.16−43.845.62−3.82
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–1.082.614.927.71−7.66
Assets under construction, years of additionsOur threshold 2 years of additions–0.280.860.100.260.47
Effective tax ratePublished threshold 17.16 per cent25.3125.1425.9431.7934.2729.86
Tax charged less tax paid, % of profitOur threshold 10 percentage points–0.02−3.544.760.97−1.24
A threshold marked as ours has no published figure; it is the line we read the check against.